BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 23737552)

  • 21. Measles virus P protein suppresses Toll-like receptor signal through up-regulation of ubiquitin-modifying enzyme A20.
    Yokota S; Okabayashi T; Yokosawa N; Fujii N
    FASEB J; 2008 Jan; 22(1):74-83. PubMed ID: 17720800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucocorticoid and TNF signaling converge at A20 (TNFAIP3) to repress airway smooth muscle cytokine expression.
    Sasse SK; Altonsy MO; Kadiyala V; Cao G; Panettieri RA; Gerber AN
    Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L421-32. PubMed ID: 27371733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration.
    Xiao N; Li H; Luo J; Wang R; Chen H; Chen J; Wang P
    Biochem J; 2012 Feb; 441(3):979-86. PubMed ID: 22029577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein Kinase-Mediated Decision Between the Life and Death.
    Engin A
    Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells.
    Awane M; Andres PG; Li DJ; Reinecker HC
    J Immunol; 1999 May; 162(9):5337-44. PubMed ID: 10228009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TNF-α-induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade-driven IL-17A expression.
    Urbano PCM; Aguirre-Gamboa R; Ashikov A; van Heeswijk B; Krippner-Heidenreich A; Tijssen H; Li Y; Azevedo VF; Smits LJT; Hoentjen F; Joosten I; Koenen HJPM
    J Allergy Clin Immunol; 2018 Aug; 142(2):517-529. PubMed ID: 29248493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-17R deletion predicts high-grade colorectal cancer and poor clinical outcomes.
    Yan C; Huang WY; Boudreau J; Mayavannan A; Cheng Z; Wang J
    Int J Cancer; 2019 Jul; 145(2):548-558. PubMed ID: 30628053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elucidating dynamic protein-protein interactions and ubiquitination in NF-κB signaling pathways.
    Shembade N; Harhaj EW
    Methods Mol Biol; 2015; 1280():283-95. PubMed ID: 25736755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2.
    Van Huffel S; Delaei F; Heyninck K; De Valck D; Beyaert R
    J Biol Chem; 2001 Aug; 276(32):30216-23. PubMed ID: 11390377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling.
    Shembade N; Parvatiyar K; Harhaj NS; Harhaj EW
    EMBO J; 2009 Mar; 28(5):513-22. PubMed ID: 19131965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. O-Linked β-N-Acetylglucosamine Modification of A20 Enhances the Inhibition of NF-κB (Nuclear Factor-κB) Activation and Elicits Vascular Protection After Acute Endoluminal Arterial Injury.
    Yao D; Xu L; Xu O; Li R; Chen M; Shen H; Zhu H; Zhang F; Yao D; Chen YF; Oparil S; Zhang Z; Gong K
    Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1309-1320. PubMed ID: 29622561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant Low Expression of A20 in Tumor Necrosis Factor-α-stimulated SLE Monocytes Mediates Sustained NF-κB Inflammatory Response.
    Shi X; Qian T; Li M; Chen F; Chen Y; Hao F
    Immunol Invest; 2015; 44(5):497-508. PubMed ID: 26107748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20.
    Lin R; Yang L; Nakhaei P; Sun Q; Sharif-Askari E; Julkunen I; Hiscott J
    J Biol Chem; 2006 Jan; 281(4):2095-103. PubMed ID: 16306043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative distribution of protein components of the A20 ubiquitin-editing complex in normal human brain.
    Pranski EL; Van Sanford CD; Dalal NV; Orr AL; Karmali D; Cooper DS; Costa N; Heilman CJ; Gearing M; Lah JJ; Levey AI; Betarbet RS
    Neurosci Lett; 2012 Jun; 520(1):104-9. PubMed ID: 22634524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of optineurin as an interleukin-1 receptor-associated kinase 1-binding protein and its role in regulation of MyD88-dependent signaling.
    Tanishima M; Takashima S; Honda A; Yasuda D; Tanikawa T; Ishii S; MaruYama T
    J Biol Chem; 2017 Oct; 292(42):17250-17257. PubMed ID: 28882891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A20 promotes liver regeneration by decreasing SOCS3 expression to enhance IL-6/STAT3 proliferative signals.
    da Silva CG; Studer P; Skroch M; Mahiou J; Minussi DC; Peterson CR; Wilson SW; Patel VI; Ma A; Csizmadia E; Ferran C
    Hepatology; 2013 May; 57(5):2014-25. PubMed ID: 23238769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-beta-activated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and IkappaB kinase gamma and increases A20 expression.
    Xiong Y; Qiu F; Piao W; Song C; Wahl LM; Medvedev AE
    J Biol Chem; 2011 Mar; 286(10):7905-7916. PubMed ID: 21220427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A20 is induced by Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 and blocks K13-induced nuclear factor-kappaB in a negative feedback manner.
    Matta H; Gopalakrishnan R; Punj V; Yi H; Suo Y; Chaudhary PM
    J Biol Chem; 2011 Jun; 286(24):21555-64. PubMed ID: 21531730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased A20-E3 ubiquitin ligase interactions in bid-deficient glia attenuate TLR3- and TLR4-induced inflammation.
    Kinsella S; Fichtner M; Watters O; König HG; Prehn JHM
    J Neuroinflammation; 2018 May; 15(1):130. PubMed ID: 29720226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-17 receptor signaling inhibits C/EBPbeta by sequential phosphorylation of the regulatory 2 domain.
    Shen F; Li N; Gade P; Kalvakolanu DV; Weibley T; Doble B; Woodgett JR; Wood TD; Gaffen SL
    Sci Signal; 2009 Feb; 2(59):ra8. PubMed ID: 19244213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.